4//SEC Filing
Ferayorni Justin John 4
Accession 0001493152-24-005536
CIK 0001008586other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 9:47 PM ET
Size
9.1 KB
Accession
0001493152-24-005536
Insider Transaction Report
Form 4
Ferayorni Justin John
Director
Transactions
- Award
Warrant (right to buy)
2024-02-07$0.38/sh+460,526$175,000→ 460,526 total(indirect: Refer to footnote.)Exercise: $0.38From: 2024-02-07Exp: 2028-02-07→ Common Stock, $0.01 par value (460,526 underlying)
Holdings
- 583,633
Common Stock, $0.01 par value
- 4,930,882(indirect: Refer to footnote.)
Common Stock, $0.01 par value
Footnotes (5)
- [F1]The reported securities represent shares owned directly by Mr. Ferayorni.
- [F2]The reported securities represent 4,244,334 shares held directly by Tamarack Global Healthcare Fund, L.P. ("Fund 1") and 686,548 shares held directly by Tamarack Global Healthcare Fund QP, L.P. ("Fund 2"). Tamarack Capital Management, LLC is the general partner of Fund 1 and Fund 2, Tamarack Advisors, LP is the investment advisor to Fund 1 and Fund 2, and Justin J. Ferayorni is the sole managing member of both Tamarack Capital Management, LLC and Tamarack Capital GP, LLC. Tamarack Capital Management, LLC, Tamarack Advisors, LP, and Mr. Ferayorni may be deemed indirect beneficial owners of the shares held by Fund 1 and Fund 2 for purposes of Section 13(d) of the Securities Exchange Act of 1934 (the "Act").
- [F3]Tamarack Capital Management, LLC, Tamarack Advisors, LP, and Mr. Ferayorni disclaim beneficial ownership of any of the shares held by Fund 1 and Fund 2 for the purpose of determining whether they are subject to Section 16 of the Act, however, in reliance on Rule 16a-1(a)(v) and (vii) under the Act. To the extent that they might be deemed subject to Section 16, they disclaim beneficial ownership of securities held by the Fund 1 and Fund 2 for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein, if any.
- [F4]Reflects a warrant to purchase 460,526 shares of the Issuer's common stock, par value $0.01 per share, acquired in connection with a private placement offering by the Issuer. The Warrant has an exercise price of $0.38 per share, is exercisable immediately, and will expire on February 7, 2028.
- [F5]The reported securities are owned directly by The Ferayorni Family Trust for which Mr. Ferayorni serves as trustee.
Documents
Issuer
STREAMLINE HEALTH SOLUTIONS INC.
CIK 0001008586
Entity typeother
Related Parties
1- filerCIK 0001790497
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 9:47 PM ET
- Size
- 9.1 KB